Prestige Consumer Healthcare (PBH) Earnings Analysis

Prestige Consumer Healthcare (PBH) next reports earnings on 2026-08-06, consensus EPS 0.89 USD. Last quarter (2026-02-05) it missed with EPS 1.14 USD vs 1.16 USD est (-1.7%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E 12.44.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PBH next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.89 USD
Revenue estimate0.25B

PBH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-051.14 USD1.16 USD-1.7%Miss
2025-11-061.07 USD0.97 USD+10.3%Beat
2025-08-070.95 USD1.01 USD-5.9%Miss
2025-05-081.32 USD1.3 USD+1.5%Beat
2025-02-061.22 USD1.16 USD+5.2%Beat
2024-11-071.09 USD1.08 USD+0.9%Beat
2024-08-080.9 USD0.86 USD+4.7%Beat

Beat rate: 5/7 (71%) over reported quarters with consensus data.

PBH valuation and analyst view

Trailing P/E12.44
Trailing EPS4.012 USD
Price / book1.23
Dividend yield0.00%
Market cap2.35B
Analyst consensusBuy (11 buy / 4 hold / 2 sell)
Avg price target68.5 USD

Related research pages

Frequently asked questions

When is Prestige Consumer Healthcare (PBH)'s next earnings date?

Prestige Consumer Healthcare is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.89 USD and revenue estimate of 0.25B.

Did PBH beat earnings last quarter?

In its 2026-02-05 report, PBH posted EPS of 1.14 USD versus a 1.16 USD estimate — a miss of 1.7%.

What is PBH's earnings track record?

Over the last 7 reported quarters with consensus data, PBH beat estimates 5 times (71%).

What is PBH's current P/E ratio and EPS?

PBH trades at a trailing P/E of 12.44 on trailing EPS of 4.011995867855712 USD.

What do analysts rate PBH?

Analyst consensus is "Buy" across 17 ratings (0 strong buy, 11 buy, 4 hold, 2 sell, 0 strong sell). Average 12-month price target: 68.5 USD.